Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuliana S Zuccoli

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|August 27, 2022
Mitochondrial Dysregulation and the Influence in Neurodegenerative DiseasesGiuliana S Zuccoli, Victor Corasolla Carregari
Advances in Experimental Medicine and Biology|September 8, 2019
Effects on Glial Cell Glycolysis in Schizophrenia: An Advanced Aging Phenotype?Giuliana S Zuccoli, Paul C Guest, Daniel Martins-de-Souza
Advances in Experimental Medicine and Biology|August 5, 2022
Modeling Schizophrenia In Vitro: Challenges and Insights on Studying Brain CellsCaroline Brandão-Teles, Giuliana S Zuccoli, Bradley J Smith, et al.
Frontiers in Neuroscience|September 23, 2017
The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic EvidenceGiuliana S Zuccoli, Verônica M Saia-Cereda, Juliana M Nascimento, et al.
Advances in Experimental Medicine and Biology|August 5, 2022
Molecular Findings Guiding the Modulation of the Endocannabinoid System as a Potential Target to Treat SchizophreniaGiuliana S Zuccoli, Caroline Brandão-Teles, Gabriela Maciel Vieira, et al.
Advances in Experimental Medicine and Biology|March 30, 2017
Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric DisordersGiuliana S Zuccoli, Daniel Martins-de-Souza, Paul C Guest, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 11, 2023
Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophreniaGiuliana S Zuccoli, Juliana M Nascimento, Pedro M Moraes-Vieira, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 22, 2021
Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytesGiuliana S Zuccoli, Guilherme Reis-de-Oliveira, Bruna Garbes, et al.
Journal of Personalized Medicine|September 23, 2022
Protein Succinylation and Malonylation as Potential Biomarkers in SchizophreniaBradley Joseph Smith, Caroline Brandão-Teles, Giuliana S Zuccoli, et al.
Biochemical Society Transactions|January 30, 2024
Induced-pluripotent stem cells and neuroproteomics as tools for studying neurodegenerationCaroline Brandão-Teles, Giuliana S Zuccoli, Talita Aparecida de Moraes Vrechi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|August 27, 2022
Mitochondrial Dysregulation and the Influence in Neurodegenerative DiseasesGiuliana S Zuccoli, Victor Corasolla Carregari
Advances in Experimental Medicine and Biology|September 8, 2019
Effects on Glial Cell Glycolysis in Schizophrenia: An Advanced Aging Phenotype?Giuliana S Zuccoli, Paul C Guest, Daniel Martins-de-Souza
Advances in Experimental Medicine and Biology|August 5, 2022
Modeling Schizophrenia In Vitro: Challenges and Insights on Studying Brain CellsCaroline Brandão-Teles, Giuliana S Zuccoli, Bradley J Smith, et al.
Frontiers in Neuroscience|September 23, 2017
The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic EvidenceGiuliana S Zuccoli, Verônica M Saia-Cereda, Juliana M Nascimento, et al.
Advances in Experimental Medicine and Biology|August 5, 2022
Molecular Findings Guiding the Modulation of the Endocannabinoid System as a Potential Target to Treat SchizophreniaGiuliana S Zuccoli, Caroline Brandão-Teles, Gabriela Maciel Vieira, et al.
Advances in Experimental Medicine and Biology|March 30, 2017
Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric DisordersGiuliana S Zuccoli, Daniel Martins-de-Souza, Paul C Guest, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 11, 2023
Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophreniaGiuliana S Zuccoli, Juliana M Nascimento, Pedro M Moraes-Vieira, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 22, 2021
Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytesGiuliana S Zuccoli, Guilherme Reis-de-Oliveira, Bruna Garbes, et al.
Journal of Personalized Medicine|September 23, 2022
Protein Succinylation and Malonylation as Potential Biomarkers in SchizophreniaBradley Joseph Smith, Caroline Brandão-Teles, Giuliana S Zuccoli, et al.
Biochemical Society Transactions|January 30, 2024
Induced-pluripotent stem cells and neuroproteomics as tools for studying neurodegenerationCaroline Brandão-Teles, Giuliana S Zuccoli, Talita Aparecida de Moraes Vrechi, et al.
Pageof 2